Rafael Lopez-Urdiales

Dr. Rafael Lopez-Urdiales

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2016 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
NVNuria Vilarrasa
Nuria Vilarrasa
AGAmador García-Ruiz-de-Gordejuela
Amador García-Ruiz-de-Gordejuela
ACAnna Casajoana
Anna Casajoana
XDXevi Duran
Xevi Duran
STSilvia Toro
Silvia Toro
JPJordi Pujol
Jordi Pujol

16 August 2019 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
FPFernando Guerrero Pérez
Fernando Guerrero Pérez
ACAnna Casajoana
Anna Casajoana
CGCarmen Gómez-Vaquero
Carmen Gómez-Vaquero
NVNuria Virgili
Nuria Virgili
RLRafael Lopez-Urdiales
Rafael Lopez-Urdiales
NVNuria Vilarrasa
Nuria Vilarrasa

27 September 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TSTrevor Steward
Trevor Steward
AJAsier Juaneda-Seguí
Asier Juaneda-Seguí
GMGemma Mestre-Bach
Gemma Mestre-Bach
IMIgnacio Martínez-Zalacaín
Ignacio Martínez-Zalacaín
NVNuria Vilarrasa
Nuria Vilarrasa
Fernando Fernández-ArandaFernando Fernández-Aranda
Fernando Fernández-Aranda
Altered activity in decision-making neural circuitry may underlie the maladaptive food choices found in obesity. Here, we aimed to identify the brain regions purportedly underpinning risk-taking behavior in individuals with obesity. Twenty-three adult women with obesity and twenty-three healthy weight controls completed the Risky Gains Task during functional magnetic resonance imaging (fMRI). This task allows participants to choose between a safe option for a small, guaranteed monetary reward and risky options with larger rewards. fMRI analyses comparing losing trials to winning trials found that participants with obesity presented decreased activity in the left anterior insula in comparison to controls (p < 0.05, AlphaSim corrected). Moreover, left insula activation during losses vs. wins was negatively correlated with UPPS-P questionnaire sensation seeking scores. During safe vs. risky trials following a loss, the control group exhibited increased activation in the ventromedial prefrontal cortex (vmPFC) (p < 0.05, AlphaSim corrected) in comparison to the OB group. Moreover, vmPFC response in the obesity group during post-loss trials was negatively correlated with risky choices on the task overall. As a whole, our findings support that diminished tuning of the insula towards interoceptive signals may lead to a lack of input to the vmPFC when weighing the costs and benefits of risky choices.

Verified
Journal Article
Open access
PDF file
FPFernando Guerrero Pérez
Fernando Guerrero Pérez
ACAnna Casajoana
Anna Casajoana
CGCarmen Gómez-Vaquero
Carmen Gómez-Vaquero
NVNuria Virgili
Nuria Virgili
RLRafael Lopez-Urdiales
Rafael Lopez-Urdiales
NVNuria Vilarrasa
Nuria Vilarrasa
There is scant evidence of the long-term effects of bariatric surgery on bone mineral density (BMD). We compared BMD changes in patients with severe obesity and type 2 diabetes (T2D) 5 years after randomization to metabolic gastric bypass (mRYGB), sleeve gastrectomy (SG) and greater curvature plication (GCP). We studied the influence of first year gastrointestinal hormone changes on final bone outcomes. Forty-five patients, averaging 49.4 (7.8) years old and body mass index (BMI) 39.4 (1.9) kg/m2, were included. BMD at lumbar spine (LS) was lower after mRYGB compared to SG and GCP: 0.89 [0.82;0.94] vs. 1.04 [0.91;1.16] vs. 0.99 [0.89;1.12], p = 0.020. A higher percentage of LS osteopenia was present after mRYGB 78.6% vs. 33.3% vs. 50.0%, respectively. BMD reduction was greater in T2D remitters vs. non-remitters. Weight at fifth year predicted BMD changes at the femoral neck (FN) (adjusted R2: 0.3218; p = 0.002), and type of surgery (mRYGB) and menopause predicted BMD changes at LS (adjusted R2: 0.2507; p < 0.015). In conclusion, mRYGB produces higher deleterious effects on bone at LS compared to SG and GCP in the long-term. Women in menopause undergoing mRYGB are at highest risk of bone deterioration. Gastrointestinal hormone changes after surgery do not play a major role in BMD outcomes.

27 May 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
JFJose Abuín Fernández
Jose Abuín Fernández
MTMaría José Tapia-Guerrero
María José Tapia-Guerrero
RLRafael Lopez-Urdiales
Rafael Lopez-Urdiales
SHSandra Herranz-Antolín
Sandra Herranz-Antolín
JAJosé Manuel García Almeida
José Manuel García Almeida
GOGABRIEL OLVEIRA
GABRIEL OLVEIRA
There are no studies that have specifically assessed the role of intravenous lipid emulsions (ILE) enriched with fish oil in people with diabetes receiving total parenteral nutrition (TPN). The objective of this study was to assess the metabolic control (glycemic and lipid) and in-hospital complications that occurred in non-critically ill inpatients with TPN and type 2 diabetes with regard to the use of fish oil emulsions compared with other ILEs. We performed a post-hoc analysis of the Insulin in Parenteral Nutrition (INSUPAR) trial that included patients who started with TPN for any cause and that would predictably continue with TPN for at least five days. The study included 161 patients who started with TPN for any cause. There were 80 patients (49.7%) on fish oil enriched ILEs and 81 patients (50.3%) on other ILEs. We found significant decreases in triglyceride levels in the fish oil group compared to the other patients. We did not find any differences in glucose metabolic control: mean capillary glucose, glycemic variability, and insulin dose, except in the number of mild hypoglycemic events that was significantly higher in the fish oil group. We did not observe any differences in other metabolic, liver or infectious complications, in-hospital length of stay or mortality.
1

6 August 2023 in Obesity
Verified
Journal Article
Open access
PMPablo Maturana‐Quijada
Pablo Maturana‐Quijada
TSTrevor Steward
Trevor Steward
NVNuria Vilarrasa
Nuria Vilarrasa
RMRomina Miranda‐Olivos
Romina Miranda‐Olivos
Susana Jiménez-MurciaSusana Jiménez-Murcia
Susana Jiménez-Murcia
Fernando Fernández-ArandaFernando Fernández-Aranda
Fernando Fernández-Aranda
Objective: The regulation of negative emotions entails the modulation of subcortical regions, such as the amygdala, by prefrontal regions. There is preliminary evidence suggesting that individuals at higher weight may present with hypoactivity in prefrontal regulatory systems during emotional regulation, although the directionality of these pathways has not been tested. In this study, we compared fronto‐amygdalar effective connectivity during cognitive reappraisal as a function of BMI in 48 adult women with obesity and 54 control participants.Methods: Dynamic causal modeling and parametric empirical Bayes were used to map effective connectivity between the dorsomedial prefrontal cortex, orbitofrontal cortex, dorsolateral prefrontal cortex, and the amygdala.Results: Difficulty in Emotion Regulation Scale scores were higher in the obesity group compared with control participants (p < 0.001). A top‐down cortical model best explained our functional magnetic resonance imaging data (posterior probability = 86%). Participants at higher BMI were less effective at inhibiting activity in the amygdala via the orbitofrontal cortex and dorsomedial prefrontal cortex during reappraisal compared with those at lower BMI. In contrast, increased excitatory modulation of dorsolateral prefrontal cortex‐to‐amygdalar connectivity was found in participants at lower BMI.Conclusions: These findings support a framework involving alterations in fronto‐amygdalar connectivity contributing to difficulties in regulating negative affect in individuals at higher weight.